
About Qiagen India Private Limited
Data last updated:
Qiagen India Private Limited is a private limited company based in New Delhi, Delhi, India, a subsidiary of Qiagen N.V. It operates in the biotechnology segment of the life sciences sector. It was incorporated on 11 December 2009 and has been in existence for over 17 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74900DL2009PTC196804. Its GSTIN is 07AAACQ2086M1Z5 (Delhi). The company holds 3 GST registrations, all of them active.
The company has an authorised share capital of ₹115 Cr and a paid-up capital of ₹112.04 Cr. It is led by directors including Sanjay Mathur and Manoj Jagathmohan.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Space No 1 & 2 Ground Floor Corporate One Plot No 5 District Centre Jasola, New Delhi, Delhi, India – 110025.
As per the financials filed for FY 2025, the company reported a revenue of ₹211.97 Cr, a growth of 9% compared to the previous year. For the same year it recorded a net profit of ₹12.01 Cr (net margin 5.7%) and EBITDA of ₹21.47 Cr (EBITDA margin 10.1%). Revenue has grown at a compounded annual rate (CAGR) of 5% over three years and 7% over five years.
The company has about 97 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Qiagen. Court records list 8 cases involving the company, including 5 filed by the company and 3 filed against it; 5 cases are pending. The company has 4 deals on record (2 rights issues, 1 funding round, 1 secondary share transfer), with disclosed funding of ₹11.9 Cr; the latest was in August 2018.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website qiagen.com.
Company details
Contact details
Qiagen India Private Limited's registered office is in New Delhi, Delhi. Its website is qiagen.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressSpace No 1 & 2 Ground Floor Corporate One Plot No 5 District Centre Jasola, New Delhi, Delhi, India – 110025
- IndustryLife Sciences, Biotechnology
To see the full contact details of Qiagen India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Qiagen India operates one associated brand: Qiagen. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Products and reagents for molecular diagnostic assays are supplied. | qiagen.com |
Business activity
The main business activity of Qiagen India is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Qiagen India Private Limited, buy the company report.
Financials of Qiagen India Private Limited
FY 2025 filings availableQiagen India Private Limited reported revenue of ₹211.97 Cr (up 9% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 7% over five years, including 9% growth in the latest year. EBITDA rose 114% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹211.97 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹21.47 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹12.01 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 10.1% | ||||
| Net Profit Margin | 5.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Qiagen India Private Limited, buy the company report.
Board of directors of Qiagen India Private Limited
Qiagen India has 4 current directors and 16 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sanjay Mathur | Director | 11 Nov 2021 | 5 Years 0 Months | Current |
| Lin Xunlong | Additional Director | 12 Dec 2024 | 1 Years 11 Months | Current |
| Manoj Jagathmohan | Director | 26 Dec 2013 | 12 Years 10 Months | Current |
| Axel Backheuer | Additional Director | 07 Jan 2026 | 0 Years 10 Months | Current |
Auditor
Qiagen India Private Limited is audited by Walker Chandiok & Co LLP for the financial year 2025.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Walker Chandiok & Co LLP | FY 2025 | 001076N/N500013 |
Shareholding
The shareholding of Qiagen India Private Limited is on record for 5 financial years, the latest being FY 2025, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Qiagen India Private Limited, buy the company report.
Deals & funding
Qiagen India Private Limited has 4 deals on record (2 rights issues, 1 funding round, 1 secondary share transfer), with disclosed funding of ₹11.9 Cr; the latest was in August 2018.
Deals on record (4 of 4)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Aug 2018 | Rights issue | ₹56.9 Cr | Investors: Qiagen NV |
| Aug 2016 | Rights issue | ₹43.23 Cr | Investors: Qiagen NV |
| Jun 2011 | Funding round | ₹11.9 Cr | Investors: Qiagen NV |
| May 2010 | Secondary share transfer | Undisclosed | Buyer: Qiagen NV, Qiagen Benelux BV Seller: 2 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Qiagen India Private Limited has 8 court cases on record: 5 filed by Qiagen India, 3 filed against it. 5 cases are pending and 3 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 4 | 1 | 3 |
| High courts | 3 | 2 | 1 |
| Supreme Court | 1 | 0 | 1 |
Cases on record (5 of 8)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, New Delhi, Delhi | Criminal case | Filed by the company against Xydor Scientific Pvt. Ltd. | Disposed |
| District court, South East, Delhi | Civil suit | Filed by the company against an individual | Pending |
| Supreme Court | Court case | Filed by the company against Principal Commissioner of Customs (Acc Import) New Delhi | Pending |
| High Court of Delhi | Arbitration matter | Filed by the company against an individual | Pending |
| District court, New Delhi, Delhi | Cheque dishonour complaint | Filed by the company against an individual | Pending |
To see the full case history of Qiagen India Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Qiagen India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Qiagen India Private Limited has a workforce of 97 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 97 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Qiagen India Private Limited, buy the company report.
GST
Qiagen India has 3 GST registrations: 3 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAACQ2086M1Z5 | Delhi | Active | 01 Jul 2017 |
| 06AAACQ2086M1Z7 | Haryana | Active | 01 Jul 2017 |
| 29AAACQ2086M2ZY | Karnataka | Active | 31 Jul 2017 |
To see the full GST registrations and return filing status of Qiagen India Private Limited, buy the company report.
Recent activity
Qiagen India Private Limited has 19 board changes on record since 2011: 4 appointments and 15 cessations. The latest: Axel Backheuer was appointed as Additional Director on 07 Jan 2026.
10 earlier events are in the company report.
News
Frequently asked questions
Qiagen India is an active private limited company based in New Delhi, Delhi, India. The company works in biotechnology, within the life sciences industry. It was incorporated on 11 December 2009 (17+ years old) and is registered under CIN U74900DL2009PTC196804.
Qiagen India has 4 current directors:
- Sanjay Mathur - Director
- Lin Xunlong - Additional Director
- Manoj Jagathmohan - Director
- Axel Backheuer - Additional Director
The latest financial statements of Qiagen India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Qiagen India is 07AAACQ2086M1Z5, registered in Delhi. The company has 3 GST registrations in all, of which 3 are active. Other active GSTINs include 06AAACQ2086M1Z7 (Haryana), 29AAACQ2086M2ZY (Karnataka).
The CIN (Corporate Identification Number) of Qiagen India is U74900DL2009PTC196804. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Qiagen India has 8 court cases on record: 5 filed by the company and 3 filed against it. 5 are pending. Most are in the district courts.
Qiagen India was incorporated on 11 December 2009, making it 17+ years old. It is registered with the Registrar of Companies, Delhi.
Qiagen India has 4 deals on record (2 rights issues, 1 funding round, 1 secondary share transfer), with disclosed funding of ₹11.9 Cr; the latest was in August 2018.
Axel Backheuer was appointed as Additional Director on 07 Jan 2026. Lin Xunlong was appointed as Additional Director on 12 Dec 2024. Thierry Laurent Bernard ceased to be Additional Director on 28 Sep 2023. Qiagen India has 19 board changes on record in total.
Qiagen India can be reached through the website qiagen.com. Its registered office is in New Delhi, Delhi, India.

